Foundry Partners, LLC - GW PHARMACEUTICALS PLC ownership

Back to all holdings Add to watchlist

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$585,000
+35.1%
4,765
-3.7%
0.03%
+20.8%
Q1 2020$433,000
-16.2%
4,9470.0%0.02%
+26.3%
Q4 2019$517,000
-11.2%
4,947
-2.3%
0.02%
-20.8%
Q3 2019$582,000
-62.4%
5,063
-43.6%
0.02%
-60.7%
Q2 2019$1,548,000–8,982–0.06%–
 Download
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders